Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Avanos Medical stock | $32.84

Learn how to easily invest in Avanos Medical stock.

Avanos Medical Inc is a medical devices business based in the US. Avanos Medical shares (AVNS) are listed on the NYSE and all prices are listed in US Dollars. Avanos Medical employs 5,380 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Avanos Medical

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AVNS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Avanos Medical stock price (NYSE: AVNS)

Use our graph to track the performance of AVNS stocks over time.

Avanos Medical shares at a glance

Information last updated 2021-10-16.
Latest market close$32.84
52-week range$30.70 - $53.61
50-day moving average $32.14
200-day moving average $37.25
Wall St. target price$43.00
PE ratio 821
Dividend yield N/A (0%)
Earnings per share (TTM) $0.04

Buy Avanos Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Avanos Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Avanos Medical price performance over time

Historical closes compared with the close of $32.84 from 2021-10-15

1 week (2021-10-08) 2.46%
1 month (2021-09-17) -0.24%
3 months (2021-07-16) -4.98%
6 months (2021-04-16) -26.99%
1 year (2020-10-16) -13.90%
2 years (2019-10-17) -16.73%
3 years (2018-10-17) 62.01
5 years (2016-10-17) 34.03

Is Avanos Medical under- or over-valued?

Valuing Avanos Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avanos Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avanos Medical's P/E ratio

Avanos Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 821x. In other words, Avanos Medical shares trade at around 821x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Avanos Medical's EBITDA

Avanos Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $54.4 million.

The EBITDA is a measure of a Avanos Medical's overall financial performance and is widely used to measure a its profitability.

Avanos Medical financials

Revenue TTM $737.8 million
Operating margin TTM 1.86%
Gross profit TTM $390.6 million
Return on assets TTM 0.5%
Return on equity TTM 0.19%
Profit margin 0.32%
Book value $26.95
Market capitalisation $1.6 billion

TTM: trailing 12 months

Shorting Avanos Medical shares

There are currently 1.2 million Avanos Medical shares held short by investors – that's known as Avanos Medical's "short interest". This figure is 18.6% up from 1.0 million last month.

There are a few different ways that this level of interest in shorting Avanos Medical shares can be evaluated.

Avanos Medical's "short interest ratio" (SIR)

Avanos Medical's "short interest ratio" (SIR) is the quantity of Avanos Medical shares currently shorted divided by the average quantity of Avanos Medical shares traded daily (recently around 380980.67484663). Avanos Medical's SIR currently stands at 3.26. In other words for every 100,000 Avanos Medical shares traded daily on the market, roughly 3260 shares are currently held short.

However Avanos Medical's short interest can also be evaluated against the total number of Avanos Medical shares, or, against the total number of tradable Avanos Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Avanos Medical's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Avanos Medical shares in existence, roughly 30 shares are currently held short) or 0.026% of the tradable shares (for every 100,000 tradable Avanos Medical shares, roughly 26 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Avanos Medical.

Find out more about how you can short Avanos Medical stock.

Avanos Medical share dividends

We're not expecting Avanos Medical to pay a dividend over the next 12 months.

Avanos Medical share price volatility

Over the last 12 months, Avanos Medical's shares have ranged in value from as little as $30.7 up to $53.61. A popular way to gauge a stock's volatility is its "beta".

AVNS.US volatility(beta: 0.9)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Avanos Medical's is 0.9026. This would suggest that Avanos Medical's shares are less volatile than average (for this exchange).

Avanos Medical overview

Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc.

Frequently asked questions

What percentage of Avanos Medical is owned by insiders or institutions?
Currently 1.093% of Avanos Medical shares are held by insiders and 94.571% by institutions.
How many people work for Avanos Medical?
Latest data suggests 5,380 work at Avanos Medical.
When does the fiscal year end for Avanos Medical?
Avanos Medical's fiscal year ends in December.
Where is Avanos Medical based?
Avanos Medical's address is: 5405 Windward Parkway, Alpharetta, GA, United States, 30004
What is Avanos Medical's ISIN number?
Avanos Medical's international securities identification number is: US05350V1061
What is Avanos Medical's CUSIP number?
Avanos Medical's Committee on Uniform Securities Identification Procedures number is: 05350V106

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site